Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 31 04:00PM ET
5.30
Dollar change
+0.09
Percentage change
1.73
%
IndexRUT P/E- EPS (ttm)-0.83 Insider Own53.62% Shs Outstand82.83M Perf Week10.88%
Market Cap442.78M Forward P/E- EPS next Y-0.47 Insider Trans0.00% Shs Float38.75M Perf Month-10.92%
Income-68.77M PEG- EPS next Q-0.16 Inst Own47.01% Short Float17.62% Perf Quarter-32.31%
Sales235.44M P/S1.88 EPS this Y-13.79% Inst Trans11.83% Short Ratio12.66 Perf Half Y-45.75%
Book/sh1.76 P/B3.01 EPS next Y28.79% ROA-22.50% Short Interest6.83M Perf Year-38.59%
Cash/sh0.56 P/C9.47 EPS next 5Y29.80% ROE-39.76% 52W Range4.65 - 14.79 Perf YTD-57.36%
Dividend Est.- P/FCF- EPS past 5Y- ROI-26.78% 52W High-64.16% Beta0.97
Dividend TTM- Quick Ratio1.70 Sales past 5Y19.90% Gross Margin65.47% 52W Low13.98% ATR (14)0.39
Dividend Ex-Date- Current Ratio3.57 EPS Y/Y TTM4.54% Oper. Margin-23.13% RSI (14)42.46 Volatility8.28% 7.11%
Employees574 Debt/Eq0.75 Sales Y/Y TTM17.39% Profit Margin-29.21% Recom1.00 Target Price14.40
Option/ShortYes / Yes LT Debt/Eq0.75 EPS Q/Q-25.32% Payout- Rel Volume1.32 Prev Close5.21
Sales Surprise1.56% EPS Surprise-0.83% Sales Q/Q19.62% EarningsNov 12 AMC Avg Volume539.38K Price5.30
SMA20-1.50% SMA50-18.58% SMA200-39.14% Trades Volume710,152 Change1.73%
Date Action Analyst Rating Change Price Target Change
Sep-29-23Initiated William Blair Outperform
Apr-11-23Initiated Stephens Overweight $23
Dec-14-22Resumed B. Riley Securities Buy $32
Oct-30-24 07:14AM
Oct-17-24 04:42PM
04:05PM
Oct-16-24 04:05PM
11:20AM
06:00PM Loading…
Oct-09-24 06:00PM
10:00AM
Oct-02-24 08:00AM
Sep-30-24 02:34PM
Sep-25-24 09:00PM
02:17PM
Sep-17-24 08:38AM
Sep-16-24 09:00PM
Sep-11-24 06:32AM
Sep-10-24 09:00AM
05:37PM Loading…
Sep-09-24 05:37PM
Sep-05-24 06:32AM
Sep-04-24 09:15AM
Sep-03-24 09:00PM
12:53PM
Aug-28-24 11:58AM
Aug-26-24 09:00PM
04:13PM
Aug-22-24 02:27PM
Aug-20-24 07:31AM
Aug-19-24 04:41PM
Aug-14-24 05:36PM
07:00AM
Aug-13-24 02:49PM
Aug-12-24 09:00PM
11:13AM Loading…
Aug-11-24 11:13AM
Aug-08-24 09:58PM
04:10PM
12:17PM
10:00AM
Aug-05-24 03:26PM
Aug-02-24 03:56PM
Aug-01-24 07:13PM
Jul-17-24 04:05PM
May-13-24 10:30AM
May-10-24 02:36PM
May-09-24 10:16AM
07:46AM
May-08-24 10:55PM
04:05PM
May-02-24 04:05PM
Apr-04-24 11:43AM
08:01AM
Apr-01-24 10:32AM
Mar-28-24 04:05PM
04:58AM
Mar-02-24 08:54AM
Mar-01-24 06:44AM
Feb-29-24 04:35PM
04:05PM
Feb-12-24 11:36AM
Feb-06-24 04:05PM
Feb-01-24 08:00AM
Jan-30-24 04:43PM
Jan-26-24 08:00AM
Jan-17-24 08:00AM
Jan-08-24 09:00AM
Jan-05-24 08:00AM
Dec-19-23 04:05PM
Nov-20-23 10:34AM
Nov-16-23 11:31AM
Nov-14-23 04:05PM
08:00AM
Nov-13-23 04:05PM
Nov-12-23 08:55AM
Nov-08-23 08:45AM
Nov-07-23 04:05PM
04:05PM
Nov-06-23 06:42AM
Nov-03-23 08:00AM
Oct-17-23 04:05PM
Sep-11-23 07:00AM
Aug-28-23 04:05PM
Aug-02-23 05:25PM
04:05PM
Jul-28-23 08:00AM
Jul-27-23 08:35AM
Jul-12-23 04:05PM
Jun-12-23 06:34AM
May-23-23 08:00AM
May-05-23 08:42AM
May-04-23 06:55PM
04:05PM
Apr-26-23 04:05PM
Apr-24-23 04:05PM
Apr-20-23 04:05PM
Apr-18-23 05:35PM
Apr-11-23 11:49AM
Mar-03-23 08:12AM
Mar-02-23 05:35PM
04:05PM
Mar-01-23 04:05PM
Feb-28-23 05:45PM
Feb-23-23 10:00AM
Feb-17-23 02:00PM
Paragon 28, Inc. engages in operation of an orthopedic foot and ankle company. Its products include bone graft harvest system, bone marrow aspirate kits, and soft tissue fixation system. The company was founded by Albert DaCosta, Frank Bono, Jim Riegler and Lee Rosenthal in 2010 and is headquartered in Englewood, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DaCosta AlbertSee RemarksMar 15 '24Buy9.1228,000255,2265,339,110Mar 18 05:34 PM
DaCosta Albertsee remarksNov 10 '23Buy8.5130,500259,5555,311,110Nov 13 08:00 AM
Last Close
Oct 31 04:00PM ET
2.82
Dollar change
-0.11
Percentage change
-3.60
%
AKYA Akoya Biosciences Inc daily Stock Chart
IndexRUT P/E- EPS (ttm)-1.23 Insider Own55.32% Shs Outstand49.12M Perf Week-1.92%
Market Cap139.34M Forward P/E- EPS next Y-0.55 Insider Trans-0.05% Shs Float22.11M Perf Month5.04%
Income-60.35M PEG- EPS next Q-0.32 Inst Own24.17% Short Float9.14% Perf Quarter26.80%
Sales93.22M P/S1.49 EPS this Y29.22% Inst Trans-23.02% Short Ratio13.58 Perf Half Y-29.45%
Book/sh0.45 P/B6.26 EPS next Y46.03% ROA-36.29% Short Interest2.02M Perf Year-19.57%
Cash/sh0.91 P/C3.08 EPS next 5Y- ROE-128.20% 52W Range1.88 - 6.31 Perf YTD-42.32%
Dividend Est.- P/FCF- EPS past 5Y-37.60% ROI-58.24% 52W High-55.39% Beta1.36
Dividend TTM- Quick Ratio1.98 Sales past 5Y23.82% Gross Margin53.01% 52W Low49.73% ATR (14)0.18
Dividend Ex-Date- Current Ratio2.73 EPS Y/Y TTM37.72% Oper. Margin-51.65% RSI (14)47.45 Volatility6.15% 6.60%
Employees330 Debt/Eq3.81 Sales Y/Y TTM9.66% Profit Margin-64.74% Recom2.00 Target Price5.00
Option/ShortYes / Yes LT Debt/Eq3.66 EPS Q/Q48.02% Payout- Rel Volume0.59 Prev Close2.92
Sales Surprise-1.13% EPS Surprise-1.35% Sales Q/Q-1.52% EarningsAug 05 AMC Avg Volume148.73K Price2.82
SMA20-5.50% SMA501.10% SMA200-18.23% Trades Volume87,396 Change-3.60%
Date Action Analyst Rating Change Price Target Change
Aug-06-24Downgrade Morgan Stanley Overweight → Equal-Weight
Aug-06-24Downgrade JP Morgan Overweight → Neutral
Aug-06-24Downgrade BTIG Research Buy → Neutral
Jun-21-24Initiated Craig Hallum Buy $7.50
Dec-14-23Initiated Guggenheim Neutral
Jul-05-23Resumed JP Morgan Overweight $18
Feb-02-23Initiated UBS Buy $14
Nov-03-22Initiated CapitalOne Overweight $19
Oct-06-22Initiated Stephens Overweight $16
Jun-22-22Initiated BTIG Research Buy $16
Oct-28-24 08:30AM
Oct-07-24 08:00AM
Oct-03-24 04:00PM
Aug-05-24 08:59PM
05:10PM
04:07PM Loading…
04:07PM
04:00PM
Jul-15-24 04:00PM
May-15-24 08:02AM
May-14-24 01:55PM
09:01AM
08:14AM
07:34AM
May-13-24 08:54PM
05:35PM
04:36PM Loading…
04:36PM
04:00PM
May-09-24 08:00AM
May-06-24 10:00AM
08:00AM
May-02-24 08:00AM
Apr-22-24 04:05PM
Apr-05-24 08:00AM
Mar-05-24 09:52AM
07:00AM
Mar-04-24 08:51PM
05:31PM
05:15PM
04:21PM
04:05PM
04:05PM Loading…
Feb-08-24 04:05PM
Feb-07-24 04:13AM
Jan-18-24 08:00AM
Jan-10-24 08:00AM
Jan-08-24 01:07AM
Jan-07-24 08:00AM
08:00AM
08:00AM
Jan-05-24 08:34AM
Dec-27-23 09:55AM
Dec-20-23 08:05AM
Nov-12-23 10:51AM
Nov-09-23 10:25AM
Nov-08-23 05:51PM
04:05PM
04:00PM
Nov-02-23 08:00AM
Nov-01-23 10:01AM
Oct-31-23 09:00AM
Oct-17-23 10:22AM
Oct-11-23 04:05PM
Sep-19-23 08:00AM
Aug-17-23 09:56AM
Aug-08-23 12:38PM
Aug-07-23 06:15PM
05:02PM
04:05PM
08:05AM
Aug-06-23 10:57AM
Jul-26-23 04:05PM
Jul-21-23 09:21AM
Jul-12-23 09:55AM
08:05AM
Jul-10-23 10:08AM
Jun-13-23 07:58PM
12:32PM
08:29AM
06:37AM
Jun-12-23 04:05PM
Jun-08-23 12:55AM
Jun-07-23 04:08PM
May-09-23 10:43AM
May-08-23 05:35PM
04:32PM
04:05PM
May-05-23 07:36AM
Apr-27-23 08:00AM
Apr-17-23 12:20PM
Apr-14-23 03:38PM
Apr-12-23 08:00AM
08:00AM
Apr-06-23 08:00AM
Mar-20-23 04:00PM
Mar-09-23 05:17AM
Mar-08-23 07:21AM
Mar-07-23 09:52AM
Mar-06-23 05:35PM
04:05PM
Feb-28-23 08:00AM
Feb-27-23 10:00AM
Feb-10-23 06:36PM
Feb-06-23 08:05AM
Feb-01-23 08:00AM
Jan-08-23 04:00PM
Jan-06-23 08:00AM
Dec-28-22 04:00PM
Dec-15-22 04:00PM
Dec-07-22 05:15AM
Nov-07-22 05:25PM
04:05PM
Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. Akoya offers two distinct solutions, the CODEX and Phenoptics platforms, to serve the diverse needs of researchers across discovery, translational and clinical research. The company was founded by Garry Nolan, Yury Goltsev and Nikolay Samusik in 2015 and is headquartered in Marlborough, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McKelligon BrianPresident and CEOJun 11 '24Option Exercise0.307,5002,272232,233Jun 12 04:01 PM
McKelligon BrianPresident and CEOJun 11 '24Sale2.087,50015,630224,733Jun 12 04:01 PM
McKelligon BrianPresident and CEOJun 06 '24Option Exercise0.307,5002,272232,233Jun 07 09:56 PM
McKelligon BrianPresident and CEOJun 06 '24Sale2.017,50015,064224,733Jun 07 09:56 PM
McKelligon BrianPresident and CEOMar 20 '24Option Exercise0.307,5002,272239,368Mar 22 05:54 PM
McKelligon BrianPresident and CEOMar 20 '24Sale4.977,50037,243231,868Mar 22 05:54 PM
McKelligon BrianPresident and CEOMar 13 '24Sale4.947,50037,035224,368Mar 14 08:41 PM
McKelligon BrianPresident and CEODec 19 '23Option Exercise0.307,5002,272160,063Dec 20 07:16 PM
McKelligon BrianPresident and CEODec 19 '23Sale4.487,50033,566152,563Dec 20 07:16 PM
McKelligon BrianPresident and CEODec 12 '23Option Exercise0.307,5002,272160,063Dec 14 04:24 PM
McKelligon BrianPresident and CEODec 12 '23Sale4.257,50031,871152,563Dec 14 04:24 PM
McKelligon BrianPresident and CEONov 20 '23Option Exercise0.307,5002,272160,063Nov 22 04:00 PM
McKelligon BrianPresident and CEONov 20 '23Sale4.397,50032,901152,563Nov 22 04:00 PM